KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Asset Writedowns and Impairment (2017 - 2025)

Amneal Pharmaceuticals (AMRX) has 9 years of Asset Writedowns and Impairment data on record, last reported at $16000.0 in Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 100.03% year-over-year to $16000.0; the TTM value through Dec 2025 reached $22.8 million, up 2378.26%, while the annual FY2025 figure was $22.8 million, 2378.26% up from the prior year.
  • Asset Writedowns and Impairment reached $16000.0 in Q4 2025 per AMRX's latest filing, down from $22.8 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $62.7 million in Q3 2024 and bottomed at -$62.7 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 5 years is $11.3 million, with a median of $15.1 million recorded in 2021.
  • Peak YoY movement for Asset Writedowns and Impairment: soared 2100.45% in 2023, then crashed 447.34% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $15.4 million in 2021, then surged by 194.8% to $45.3 million in 2022, then crashed by 60.17% to $18.0 million in 2023, then plummeted by 447.34% to -$62.7 million in 2024, then skyrocketed by 100.03% to $16000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $16000.0 in Q4 2025, $22.8 million in Q3 2025, and -$62.7 million in Q4 2024.